01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology

Chen J, Stickles RJ, Daichendt KA (1994) Galactosylated
histone-mediated gene transfer and expression. Hum Gene
Ther 5, 429-435.
Chen LM, Chao L, Chao J (1997) Adenovirus-mediated delivery
of human kallistatin gene reduces blood pressure of
spontaneously hypertensive rats. Hum Gene Ther 8, 341-
347.
Chen PL, Chen Y, Shan B, Bookstein R, Lee WH (1992)
Stability of retinoblastoma gene expression determines the
tumorigenicity of reconstituted retinoblastoma cells. Cell
Growth Differ 3, 119-125
Chen SH, Kosai K, Xu B, Pham-Nguyen K, Contant C, Finegold
MJ, Woo SL (1996) Combination suicide and cytokine gene
therapy for hepatic metastases of colon carcinoma: sustained
antitumor immunity prolongs animal survival. Cancer Res
56, 3758-3762.
Chen SJ, Wilson JM, Vallance DK, Hartman JW, Davidson BL,
Roessler BJ (1995) A recombinant adenoviral vector
expressing a soluble form of VCAM-1 inhibits VCAM-
1/VLA-4 adhesion in transduced synoviocytes. Gene Ther 2,
469-480.
Chen ST, Iida A, Guo L, Friedmann T, Yee JK (1996)
Generation of packaging cell lines for pseudotyped retroviral
vectors of the G protein of vesicular stomatitis virus by using
a modified tetracycline inducible system. Proc Natl Acad
Sci USA 93, 10057-10062.
Chen X, Farmer G, Zhu H, Prywes R, Prives C (1993)
Cooperative DNA binding of p53 with TFIID (TBP): A
possible mechanism for transcriptional activation. Genes
Dev 7, 1837-1849.
Chen Y, Chen C-F, Riley DJ, Allred DC, Chen P-L, Von Hoff D,
Osborne CK, and Lee W-H (1995) Aberrant subcellular
localization of BRCA1 in breast cancer. Science 270, 789-
791.
Chen YM, Chen PL, Arnaiz N, Goodrich D, Lee WH (1991)
Expression of wild-type p53 in human A673 cells suppresses
tumorigenicity but not growth rate. Oncogene 6, 1799-1805.
Chen P-L , Scully, P., Shew, J.-Y., Wang, J.Y.J. and Lee, W.-H.
(1989) Phosphorylation of the retinoblastoma gene product is
modulated during the cell cycle and cellular differentiation.
Cell 58, 1193-1198.
Chernajovsky Y, Adams G, Triantaphyllopoulos K, Ledda MF,
Podhajcer OL (1997) Pathogenic lymphoid cells engineered
to express TGF β 1 ameliorate disease in a collagen-induced
arthritis model. Gene Ther 4, 553-559
Chi SG, de Vere White RW, Meyers FJ,. Siders DB, Lee F, and
Gumerlock PH (1994) p53 in prostate cancer: frequent
expressed transition mutations. J Natl Cancer Inst 86, 926-
933.
Chin K-V, Ueda K, Pastan I, Gottesman MM (1992) Modulation
of activity of the promoter of the human MDR1 gene by Ras
and p53. Science 255, 459-462.
Chintala SK, Fueyo J, Gomez-Manzano C, Venkaiah B, Bjerkvig
R, Yung WK, Sawaya R, Kyritsis AP, Rao JS (1997)
Adenovirus-mediated p16/CDKN2 gene transfer suppresses
glioma invasion in vitro. Oncogene 15, 2049-2057.
Gene Therapy and Molecular Biology Vol 1, page 135
135
Chiou S, Rao L, and White E (1994) Bcl-2 blocks p53-dependent
apoptosis. Mol Cell Biol 14, 1556-1563.
Choate KA and Khavari PA (1997) Direct cutaneous gene
delivery in a human genetic skin disease. Hum Gene Ther
8, 1659-1665.
Chowdhury JR, Grossman M, Gupta SJ, Chowdhury NR, Baker
Jr JR, Wilson JM (1991) Long term improvement of
hypercholesterolemia after ex vivo gene therapy in LDLRdeficient
rabbits. Science 254, 1802-1805.
Christofori G, Naik P, and Hanahan D (1995) Vascular
endothelial growth factor and its receptors, flt-1 and flk-1, are
expressed in normal pancreatic islets and throughout islet
cell tumorigenesis. Mol Endocrinol 9, 1760-1770.
Chuah MKL, Vandendriessche T, and Morgan RA (1995)
Development and analysis of retroviral vectors expressing
human factor VIII as a potential gene therapy for hemophilia
A. Hum Gene Ther 6, 1363-1377.
Cichy J, Potempa J, Travis J (1997) Biosynthesis of α1proteinase
inhibitor by human lung-derived epithelial cells. J
Biol Chem 272, 8250-8255.
Clark KR, Voulgaropoulou F, Fraley DM, and Johnson PR
(1995) Cell lines for the production of recombinant adenoassociated
virus. Hum Gene Ther 6, 1329-1341.
Clark KR, Voulgaropoulou F, Johnson PR (1996) A stable cell
line carrying adenovirus-inducible rep and cap genes allows
for infectivity titration of adeno-associated virus vectors.
Gene Ther 3, 1124-1132.
Clark SJ, Harrison J, Molloy PL (1997) Sp1 binding is inhibited
by m Cp m CpG methylation. Gene 195, 67-71.
Clarke MF, Apel IJ, Benedict MA, Eipers PG, Sumantran V,
Gonzalez-Garcia M, Doedens M, Fukunaga N, Davidson B,
Dick JE, et al (1995) A recombinant bcl-xs adenovirus
selectively induces apoptosis in cancer cells but not in
normal bone marrow cells. Proc Natl Acad Sci USA 92,
11024-11028.
Clary BM, Coveney EC, Philip R, Blazer DG 3rd, Morse M,
Gilboa E, Lyerly HK (1997) Inhibition of established
pancreatic cancers following specific active immunotherapy
with interleukin-2 gene-transduced tumor cells. Cancer
Gene Ther 4, 97-104.
Cleat PH and Hay RT (1989) Co-operative interactions between
NFI and the adenovirus DNA binding protein at the
adenovirus origin of replication. EMBO J. 8, 1841-1848.
Coenjaerts FEJ, De Vries E, Pruijn GJM, van Driel W. Bloemers
SM, van der Lugt MT, and van der Vliet PC (1991)
Enhancement of DNA replication by transcription factors
NFI and NFIII/Oct-1 depends critically on the positions of
their binding sites in the adenovirus origin of replication.
Biochim. Biophys. Acta 1090, 61-69.
Colak A, Goodman JC, Chen S-H, Woo SLC, Grossman RG,
Shine HD (1995) Adenovirus-mediated gene therapy in an
experimental model of breast cancer metastatic to the brain.
Hum Gene Ther 6, 1317-1322.
Coll JL, Wagner E, Combaret V, Metchler K, Amstutz H,
Iacono-Di-Cacito I, Simon N, Favrot MC (1997) In vitro
targeting and specific transfection of human neuroblastoma